Bajajfinsv vs Grasim Q2 FY25

Bajaj Finserv reported consolidated revenue growth of 30% YoY to ₹33,703 crore, with PAT up 8% YoY. The general insurance business (BAGIC) saw core premium growth of 11% (3x market), though headline GWP fell 20% due to a government health shift to Q3. Combined ratio worsened to 101.4% from 95.3% due to higher natural catastrophe claims. Life insurance (BALIC) grew individual retail new business by 34% YoY, but VNB margins declined 3.8pp to 9.2% due to a mix shift toward ULIPs. Bajaj Finance AUM grew 29% with strong asset quality (GNPA 1.06%). Management highlighted disciplined underwriting and risk management, but flagged near-term headwinds from regulatory changes (surrender value norms) and competitive pressure in credit life. Key risk: further margin compression in life insurance if ULIP dominance persists.

Guidance read

BALIC VNB margin improvement in H2: Management expects VNB margins to improve in H2 as product mix rebalances away from ULIPs and commission deferrals take effect. Bajaj Finserv Direct breakeven in 1-2 quarters: The marketplace business expects to break even on a cash basis within the next couple of quarters. Capital deployment of ₹500-600 crore in health & AMC by Mar'26: BFL plans to invest ₹500-600 crore in health tech and asset management over the next 18 months. BAGIC core growth to remain above market: Management expects core premium growth to continue outpacing the industry, driven by disciplined underwriting.

Risk read

Key risks include Allianz exit from JV creates strategic uncertainty — Allianz has informed Bajaj of its decision to exit the joint venture; management provided no further details, creating uncertainty around future ownership and operations.; VNB margin compression from ULIP mix and regulatory changes — VNB margins fell 3.8pp YoY to 9.2% due to higher ULIP sales; new surrender value norms may further pressure margins.; Motor TP price hike delay hurting growth — No TP price hike for three years has led to underwriting losses; management has reduced exposure, capping motor growth.; Retail health profitability under pressure — Medical inflation and hospital fraud are squeezing margins; management is cautious on growth in this segment..

Promise ledger

Of 2 tracked promises, management 0 met, 0 close, 2 missed.

Grasim's Q2 FY25 consolidated revenue grew 11% YoY to ₹33,563 crore, marking the 16th consecutive quarter of growth. However, consolidated EBITDA fell 10% YoY to ₹4,042 crore, dragged by lower profitability in cement and initial investments in the paints business (Birla Opus). The VSF division achieved its highest-ever quarterly sales volume of 219,000 tons, while chemicals EBITDA rose 16% YoY. Paints business is on track to exit FY25 with high single-digit market share, with three plants commissioned and two more starting trial runs. Management maintained guidance for Birla Opus and Birla Pivot (targeting $1B revenue in three years). Key risk: sustained competitive intensity in paints could pressure margins and delay profitability.

Guidance read

Paints: exit FY25 with high single-digit market share: Birla Opus is on track to achieve high single-digit market share in decorative paints by end of FY25, with three plants commissioned and two more starting trial runs. Birla Pivot: $1 billion revenue in three years: B2B e-commerce platform targeting $1 billion revenue within three years from FY24, with current ramp-up ahead of expectations. UltraTech: 200 MTPA cement capacity by FY27: UltraTech on track to achieve gray cement capacity of over 200 million tons per annum by FY27, including acquisitions. Net debt to EBITDA at 3.5x: Management guided net debt to EBITDA of about 3.5x, with balance rights issue of ₹2,000 crore expected in Q4.

Risk read

Key risks include Paints competitive intensity and margin pressure — Increased trade discounts and promotional spending by incumbents could pressure Birla Opus's margins and delay profitability.; Cement demand slowdown and realization decline — Cement business faced demand slowdown due to elections, heat, and extended monsoons, leading to lower realizations and impacting consolidated EBITDA.; Chlorine oversupply depressing ECU — Oversupply of chlorine led to higher negative realization, impacting chemicals ECU despite improvement in caustic prices.; Paints revenue and profitability disclosure opacity — Management declined to share specific revenue or EBITDA numbers for the paints business, citing competitive sensitivity, which limits visibility for investors..

Promise ledger

Scorecard data is being built as historical quarters are processed.